ESC 25: Heart Failure Highlights скачать в хорошем качестве

ESC 25: Heart Failure Highlights

ESC Congress 2025 - In this video, Dr Michelle Kittleson (Cedars-Sinai Heart Institute, US) outlines the hot-line data from the congress that are expected to have an impact on clinical practice in the heart failure space. Trials covered in detail include: REBOOT-CNIC: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction BETAMI-DANBLOCK: Beta-Blockers after Myocardial Infarction in Patients without Heart Failure DIGIT-HF: Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction AQUATIC: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation Recorded remotely from Los Angeles, 2025. Support: This is an independent interview produced by Radcliffe Cardiology. Visit Radcliffe Cardiology: https://www.radcliffecardiology.com/ This content is intended for healthcare professionals only. Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster. Like us on Facebook:   / radcliffecardiology   Follow us on X: https://x.com/radcliffeCARDIO